PALLIATIVE HORMONE-THERAPY IN ADVANCED BREAST-CANCER

被引：0
|
作者：
SCHRODER, W
机构：
来源：
GYNAKOLOGE | 1993年 / 26卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：131 / &
相关论文
共 50 条
  • [41] TUMOR-MARKER COURSES TO ASSESS THE EFFICACY OF CHEMOTHERAPY OR HORMONE-THERAPY IN METASTASIZING BREAST-CANCER
    MOBUS, V
    PAULA, J
    BECK, T
    CROMBACH, G
    KREIENBERG, R
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1993, 53 (01) : 24 - 29
  • [42] PALLIATIVE THERAPY FOR METASTATIC BREAST-CANCER
    PIGOTT, JD
    POSTGRADUATE MEDICINE, 1980, 67 (03) : 165 - &
  • [43] HORMONE-THERAPY FOLLOWING BREAST AND UTERINE-CANCER
    WREN, BG
    BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1993, 7 (01): : 225 - 242
  • [44] THERAPY OF ADVANCED BREAST-CANCER
    LEGHA, SS
    HORTOBAGYI, G
    BLUMENSCHEIN, GR
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (23): : 1291 - 1292
  • [45] THERAPY OF ADVANCED BREAST-CANCER
    FISCHER, DS
    KATZ, ME
    WIGGANS, RG
    CONNECTICUT MEDICINE, 1978, 42 (10) : 634 - 639
  • [46] CLINICAL-RESPONSE TO CHEMOTHERAPY AND HORMONE-THERAPY AS 1ST TREATMENT AFTER THERAPEUTIC OVARIECTOMY IN ADVANCED BREAST-CANCER PATIENTS
    PREDA, F
    ORIANA, S
    PEROZZIELLO, F
    BOTTE, G
    LORUSSO, V
    TUMORI, 1982, 68 (02) : 161 - 165
  • [47] PALLIATIVE HORMONE THERAPY IN BREAST CANCER
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1956, 2 (AUG4): : 315 - 315
  • [48] RANDOMIZED TRIAL OF CHEMO-HORMONE THERAPY IN ADVANCED BREAST-CANCER
    BOCCARDO, F
    RUBAGOTTI, A
    SERTOLI, MR
    ROSSO, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 434 - 434
  • [49] A RANDOMIZED TRIAL ON TAMOXIFEN CONTINUATION DURING 2ND-LINE HORMONE-THERAPY IN BREAST-CANCER
    PRONZATO, P
    BERTELLI, G
    ROSSO, M
    BREAST CANCER: FROM BIOLOGY TO THERAPY, 1993, 698 : 357 - 361
  • [50] Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update
    Nicolini, Andrea
    Carpi, Angelo
    Ferrari, Paola
    Biava, Pier Mario
    Rossi, Giuseppe
    CURRENT DRUG TARGETS, 2016, 17 (10) : 1127 - 1139
12345